Background
A global medical device company was evaluating the acquisition of an international manufacturer developing a high-risk, software-driven implantable medical device. While the acquiring organization had extensive experience within its existing product portfolio, the target company’s technology introduced new complexities related to software, firmware, cybersecurity, and connected medical device functionality.
To support its due diligence process, the company engaged AlvaMed to perform an independent technical assessment of the software development practices and software-related quality controls associated with the device.
The Challenge
Evaluating software-driven medical devices requires specialized expertise that extends well beyond traditional quality or regulatory due diligence.
The acquiring company wanted to better understand:
- The maturity of the target company’s software development lifecycle.
- Software architecture and development controls.
- Cybersecurity considerations for a connected implantable device.
- Software maintenance and lifecycle management practices.
- Risks that could impact future product development, regulatory compliance, manufacturing scale-up, or commercialization.
Because implantable, software-driven medical devices present unique technical and regulatory considerations, the client sought an independent software expert to supplement its internal due diligence team.
AlvaMed’s Approach
AlvaMed assigned a senior software quality and regulatory expert with decades of experience in medical device software, including direct contributions to the development of IEC 62304, the international standard governing medical device software lifecycle processes.
Working within the client’s due diligence framework, AlvaMed conducted a comprehensive review of technical documentation related to the software system, including software development processes, quality controls, cybersecurity, service and maintenance considerations, and supporting design documentation.
The assessment focused on identifying technical risks, evaluating the maturity of software development practices, and determining whether the software infrastructure could support the client’s long-term business objectives.
To enhance the depth of the review, AlvaMed also leveraged AI-assisted document analysis to:
- Summarize extensive technical documentation.
- Compare documentation against applicable regulatory expectations.
- Highlight potential areas requiring additional expert review.
Rather than replacing expert judgment, AI enabled a more comprehensive analysis within an aggressive due diligence timeline, allowing consultants to focus their attention on higher-risk technical areas.
Results
AlvaMed delivered a detailed software due diligence report that provided the client with an independent assessment of the target company’s software development practices and technical maturity.
The report included:
- An evaluation of software lifecycle processes.
- Assessment of software quality controls.
- Cybersecurity observations.
- Review of software maintenance practices.
- Technical findings prioritized by potential risk and business impact.
- Recommendations to support informed decision-making during the acquisition process.
By focusing first on the highest-risk technical areas, AlvaMed helped ensure the client gained early visibility into the most critical software considerations while continuing a comprehensive review of the supporting documentation.
Key Takeaway
As software continues to play an increasingly important role in medical devices, technical due diligence requires specialized expertise that combines software engineering, quality systems, cybersecurity, and regulatory knowledge.
Independent software due diligence helps organizations better understand technical risks, evaluate software maturity, and make informed decisions when assessing acquisition opportunities or strategic investments.
With deep expertise in medical device software, regulatory compliance, and AI-assisted technical analysis, AlvaMed helps clients perform comprehensive due diligence that supports confident business decisions while reducing technical and regulatory uncertainty.
